Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2015-08-09 Proxy Solicitation & In…
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Notice of Extraordinary General Meeting/Proxy Form 11 pages 273.9KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF EXTRAORDINARY GENERAL MEETING AND PROXY FORM' and contains detailed information about the time, place, agenda, and resolutions to be voted on at an Extraordinary General Meeting (EGM). It includes proxy voting instructions, letters from the chairman, and explanatory statements related to the resolutions. There is no financial data or report content; rather, it is a formal notice and proxy solicitation for a shareholder meeting. This matches the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document length is substantial (15,000 characters), but it is clearly a meeting notice and proxy form, not a report or announcement of a report publication. Therefore, the correct classification is PSI with high confidence.
2015-08-09 English
CDY Newsletter August 2015 6 pages 1.2MB
Management Reports Classification · 95% confidence The document is a detailed company update from Cellmid, dated August 2015, containing extensive information about recent company activities, clinical study results, collaborations, new board members, and financial fundraising through a private placement. It includes operational and strategic updates, scientific research progress, and management commentary. The content is comprehensive and covers business performance, scientific developments, and management outlook, but it does not present formal financial statements or detailed financial data typical of an Annual Report (10-K) or Interim Report (IR). It also is not a transcript of a call, a regulatory filing, or a simple announcement. The document resembles a Management Report or a detailed business update that explains company progress, trends, and outlook. Therefore, the best fitting category is Management Reports (MDA).
2015-08-05 English
Cleansing Notice and Appendix 3B 10 pages 562.1KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement titled 'Cleansing Statement - Notice under section 708A(5)(e) of the Corporations Act' related to the issue of securities pursuant to a placement. It includes detailed information about the securities issued, an Appendix 3B form which is a standard Australian Securities Exchange form for new issue announcements, application for quotation of additional securities, and agreement. The content focuses on the issuance of shares, compliance with relevant sections of the Corporations Act, and details of the placement capacity under ASX rules. There is no financial performance data, earnings information, management discussion, or audit content. The document is a regulatory announcement about capital raising and securities issuance, specifically a cleansing notice and Appendix 3B filing. This fits the category of Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes.
2015-08-04 English
Cellmid raises $4M to leverage sales growth 2 pages 88.1KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 30 July 2015 from Cellmid Limited regarding a $4 million capital raising through the issuance of new shares. It details the placement of shares, pricing, tranche structure, and the purpose of the capital raise to leverage sales growth. There are no financial statements or detailed financial performance data included, nor is this a report or presentation. The content clearly relates to a financing activity, specifically a capital raising through share issuance. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is about 4805 characters, which is consistent with an announcement rather than a full report.
2015-07-29 English
Appendix 4C - quarterly 7 pages 342.6KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement titled 'Notes to Appendix 4C and Operational Update' dated 30 July 2015. It includes detailed quarterly financial data such as cash flows from operating, investing, and financing activities, payments to directors, and a compliance statement signed by the CEO. The document references the quarter ended 30 June 2015 and provides substantive financial data and operational updates for that quarter. Appendix 4C is a recognized quarterly report format for entities admitted on the basis of commitments on the ASX, which aligns with the definition of an Interim / Quarterly Report (IR). The document is lengthy (over 12,000 characters) and contains actual financial statements and analysis, not just an announcement or summary. Therefore, it fits the category of an Interim / Quarterly Report (IR). Q4 2015
2015-07-29 English
Trading Halt 2 pages 119.6KB
Capital/Financing Update Classification · 95% confidence The document is a market release dated 28 July 2015 from Cellmid Limited announcing a trading halt of its shares pending a further announcement related to a proposed capital raising. The text explicitly states the halt is requested pending an announcement about capital raising, which is a financing activity. The document is short (1835 characters) and does not contain financial statements or detailed financial data, only a notification of the trading halt and the reason for it. Therefore, it is not a full financial report or earnings release but an update related to capital/financing activities. According to the filing definitions, this fits best under Capital/Financing Update (CAP).
2015-07-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.